Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 403-610-9 | CAS number: 122795-41-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 5 April 1988 - 17 June 1988
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 988
- Report date:
- 1988
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- -
- EC Number:
- 403-610-9
- EC Name:
- -
- Cas Number:
- 122795-41-9
- IUPAC Name:
- 1-ethyl-3-methoxytricyclo[2.2.1.0²,⁶]heptane; 2-ethyl-5-methoxybicyclo[2.2.1]heptane; 2-ethyl-6-methoxybicyclo[2.2.1]heptane
- Test material form:
- liquid
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River U.K. Limited. Marqate, Kent, England
- Age at study initiation: ~ 35 days old (on despatch)
- Weight at study initiation: ~22 and 24 g (on despatch)
- Assigned to test groups randomly: Yes
- Housing: Plastic disposable cage
- Diet: Pelleted Labsure LAD 1 rodent breeding diet ad libitum
- Water: ad libitum
- Acclimation period: ~ 4 days
ENVIRONMENTAL CONDITIONS
- Temperature: 22°C
- Air changes: 30 changes per hr
- Photoperiod: Illuminated by artificial light for 12 hours per day
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: Polyethylene glycol 400
- Concentration of test material in vehicle: Preliminary toxicity test: Phase I: 5, 10, 50, 100 and 500 mg/L. Phase II: 108, 180, 300 and 500 mg/L .
Micronucleus test: 351.9 mg/L - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: Solutions of EMN were prepared in polyethylene glycol 400 (obtained from FSA Laboratory Supplies) using a Silverson high-speed mixer.
Doses / concentrations
- Dose / conc.:
- 3 519 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- Preliminary test: Phase I - 2 mice. Phase II -5 mice
Micronucleus test: 15 mice - Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Mitomycin C, obtained from Sigma London Chemical Company Limited (batch number 96F-0547-1). Prepared as a solution in sterile 0.9% saline at a concentration of 0.6 mg/ml
- Route of administration: Oral gavage
- Doses / concentrations: 12 mg/kg
Examinations
- Tissues and cell types examined:
- Erythrocytes
- Details of tissue and slide preparation:
- Five males and five females from the negative control and test compound groups were sacrificed 24, 48 and 72 hours after dosing. The positive control group was sacrificed 24 hours after dosing. The animals were killed by cervical dislocation and both femurs dissected out from each animal. The femurs were cleared of tissue and one epiphysis removed from each bone. A direct bone marrow smear was made onto a slide containing a drop of calf serum. One smear was made from each femur. The prepared smears were air-dried and fixed in methanol (>10 minutes) and air-dried. The smears were then stained with 10% Giemsa (prepared by 1 : 9 dilution of standard Gurrts R66 Giemsa (SOH) with distilled water) . After rinsing and differentiation in buffered distilled water (pH 6.8)1 the smears were air-dried and mounted with coverslips using DPX.
The stained smears were examined (under code) by light rnicroscopy to determine the incidence of micronucleated cells per 1000 polychromatic erythrocytes per animal. The ratio of polychromatic to normochromatic erythrocytes for each animal was assessed by examination of at least 1000 erythrocytes. A record of the number of micronucleated normochomatic erythrocytes was also kept. - Evaluation criteria:
- If the ratio of the polychrorna to the normochromatic erthrocytes is scored and found to be statistically significantly less than the control value, this is taken as being indicative of toxicity.
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Preliminary toxicity test:
The details of any toxic reactions observed are given in Appendix 2a (Phase I) and Appendix 2b (phase II)
The mortality data from Phase II were subjected to probit analysis which indicated that a dose of 3519 mg/kg bodyweight would be expected to kill approximately 10% of the animals over the 72 hour exposure period (LD50 was estimated as 8390 mg/kg bodyweight). A dosage of 3519 mg EMN per kg bodyweight was chosen for use in the main test.
Micronucleus test:
An initial micronucleus test was performed using a dosage of 5000 mq/kg bodyweight EMN as indicated in the results from Phase I. However excessive mortalities at this dose level resulted in insufficient animals remaining alive after the 72 hour exposure period. Therefore a further toxicity test (Phase II) was performed to establish a more accurate estimate of the LD10.
The results of the second micronucleus test on EMN at the 24, 48 and 72 hour kill times are presented in Tables 2, 3 and 4 respectively. Table 1 gives a summary of the results and the results of statistical analysis. Appendix 4 summarises the vehicle control micronucleated polychromatic erythrocyte counts obtained in previous, unrelated experiments.
Signs and mortalities:
No animals died after treatment with EMN in.the second main study. Clinical signs are detailed in Appendix 3.
Micronucleated polychormatic erythrocyte counts (mnp):
EMN did not cause any statistically significant increases in the number of micronucleated polychromatic erythrocytes at any of the three kill times - (P>0.05 using Wilcoxon's sum of ranks test.
Mitomycin C caused large, highly significant increases (P<0.001) in the frequency of micronucleated polychromatic erythrocytes.
Micronucleated normochromatic erythrocytes (mnn):
EMN did not cause any substantial increases in the incidence of micronucleated normochromatic erythrocytes at any of the three kill times.
Ratio of polychromatic to normochromatic erythrocytes (p/n)
Both EMN and mitomycin C failed to cause any significant decreases in the ratio of polychromatic to normochromatic erythrocytes (P>0. 05 using Wilcoxon's sum of ranks test.
Any other information on results incl. tables
Table 1: Summary of results - group totals/means for the entire experiment and results of statistical analysis
Kill |
Compound |
Dosage (mg/kg) |
Ratio p/n
|
Incidence mnp |
Incidence mnn |
||
Mean |
P |
Mean o/oo |
P |
Total o/oo |
|||
24 hour |
Vehicle control
EMN
Mitomycin C |
-
3519
12 |
1.270
1.523
1.052 |
-
0.685
0.078 |
1.3
1.1
48.1 |
-
0.698
<0.001 |
0.4
0.2
0.0 |
48 hour |
Vehicle control
EMN
|
-
3519
|
1.199
1.215 |
-
0.573 |
1.4
1.5
|
-
0.370 |
0.2
0.0 |
72 hour |
Vehicle control
EMN |
-
3519 |
1.563
1.934 |
-
0.938 |
0.9
0.7 |
-
0.644 |
0.0
0.6 |
P - Results of statistical analysis using W11coxon's sum of ranks test (1-sided probabilities)
p/n - Ratio of polychromatic to normochrollatic erythrocytes
mnp - Number of micronucleated polychromatic erythrocytes observed
mnn - Number of micronucleated normochromatic erythrocytes observed
o/oo - Number per thousand cells
Please refer to attached background material for further tables of results and appendices.
Applicant's summary and conclusion
- Conclusions:
- From the results obtained it is concluded that Neoproxen shows no evidence of mutagenic potential when administered orally in this in vivo test procedure.
- Executive summary:
In this assessment of the effect of Neoproxen on the incidence of micronucleated polychromatic erythrocytes in mice, a dosage of 3519 mg/kg bodyweight was administered orally by gavage according to OECD TG 474. A preliminary toxicity test had been carried out to determine the toxicity. At all sampling times the treated mice showed no significant increase in the frequency of micronucleated polychromatic erythrocytes. There was no significant change in the ratio of polychromatic to normochromatic erythrocytes after treatment of the animals. It is concluded from the results obtained that Neoproxen shows no evidence of mutagenic potential in this in vivo test procedure.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.